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HIGHLIGHTS:
• We investigated the relevance of oxidative stress in hypoxia-induced barrier
disruption using an in vitro model.
• Prolonged hypoxic exposure induced reactive oxygen species formation and
induced glutathione oxidation.
• Pro-oxidant treatment significantly disrupted barrier function under normal
conditions.
• Anti-oxidant treatment maintained better barrier function and cell survival in an
O2-reduced environment.
• The endothelial response to oxidative stress was modulated by the presence of
astrocytes and pericytes.
ABSTRACT
The blood-brain barrier (BBB) is a cellular barrier formed by specialized brain
endothelial cells under the influence of astrocytes and pericytes. Among the several
stress factors known to induce BBB breakdown, hypoxia is probably the most
represented but also the least understood. Recent evidence of oxidative stress occurring
during hypoxia/ischemia situation raises its possible contribution to barrier breakdown.
In this study, we investigated the relevance of oxidative stress in hypoxia-induced barrier
disruption.
Prolonged hypoxic exposure induced reactive oxygen species (ROS) formation and
induced glutathione oxidation. Such effects were accentuated under extreme O2 deprived
environment. Pro-oxidant treatment significantly disrupted barrier function under normal
conditions, whereas anti-oxidant treatment contributed to maintain better barrier function
and cell survival in an O2-reduced environment. In addition, the endothelial response to
oxidative stress appeared modulated by the presence of astrocytes and pericytes, thus
explaining some of the beneficial contribution of these cells as previously described.
Taken together, this study highlights the importance of oxidative stress signaling at the
barrier. In addition, cells of the neurovascular compartment differentially modulate ROS
levels and also regulate barrier function. Thus, use of reactive oxygen scavengers may be
useful to support barrier function following stroke injury.
INTRODUCTION
The blood-brain barrier (BBB) constitutes a component of the neurovascular unit formed
by specialized brain endothelial cells (ECs) surrounded by astrocytes, pericytes and
neurons (Ogunshola, 2011; Rosenberg, 2012) . Due to the presence of important tight
junction complexes and efflux transporters, these brain ECs play an important role as
gatekeepers regulating central nervous system homeostasis.
The mammalian brain is extremely sensitive to changes in cellular homeostasis as a
result of environmental or physiological insults and neurological diseases constitute one
of the most challenging and devastating pathologies. Indeed the absence of reliable
therapies to suppress or reverse their onset show that we need to better understand the
complex mechanisms involved in progression of such diseases. Recent reviews highlight
the contribution of an important cerebrovascular component to many pathologies
including neurodegenerative diseases (Yang and Rosenberg, 2011; Zlokovic, 2011) and
data suggests that BBB dysfunction is a cause or consequence of disease progression
with overall negative outcomes.
Among the different stressors affecting the BBB integrity, two factors link impaired
BBB and neurological diseases: hypoxia and oxidative stress.
Hypoxic/ischemic challenges (i.e. reduced oxygen and/or glucose delivery) cause severe
and detrimental alterations in brain function, and can trigger neuronal cell death within
minutes. Cerebral ischemia (or stroke) induces dramatic cerebral injury and a massive
barrier disruption. Although different studies brought some crucial information on how
hypoxic stress induces barrier disruption (Bauer et al., 2010; Vogel et al., 2007; Yan et
al., 2011; Zhu et al., 2011), the mechanisms remain largely unclear.
Oxidative stress is defined as an imbalance between cellular pro-oxidants and anti-
oxidants, resulting in excessive generation of reactive free radicals in the central nervous
system (Mariani et al., 2005). Notably, presence of oxidative stress has been associated
with many neurological diseases including stroke, neurodegenerative diseases and
traumatic brain injury (Freeman and Keller, 2012). Although oxidative stress is known
to induce BBB breakdown or paracellular permeability (Clanton, 2005; Lee et al., 2004;
Lochhead et al., 2010; Yamagata et al., 2004) its contribution to hypoxia-induced barrier
breakdown remains unknown.
In this study, we investigated the contribution of hypoxia-induced oxidative stress to
barrier dysfunction in rat brain ECs.
MATERIALS AND METHODS
Cell culture & reagents
Rat brain endothelial cell line (RBE4) (Roux et al., 1994), primary rat brain astrocytes
and pericytes were isolated and cultivated as described previously (Al Ahmad et al.,
2009). Buthionine sulfoximine (BSO), desferrioxamine mesylate (DFO), reduced L-
glutathione (GSH), N-acetylcysteine (NAC) and rotenone were purchased from Sigma-
Aldrich (Buchs, Switzerland). Diphenyliodiunium (DPI) was purchased from Cayman
Chemicals (Tallinn, Estonia). 5,6-carboxy-2',7'–dichlorofluorescein (DCF) was
purchased from Invitrogen (Zug, Switzerland).
O2 deprivation-reoxygenation experiments
Cells were exposed to either hypoxic (1% O2) or near-anoxic (0.1%) conditions using a
hypoxic chamber as previously described (Al Ahmad et al., 2009). Reoxygenation phase
was achieved by replacing cell media and further expose cells to 21% O2 for 24h.
Barrier function and cell viability
Barrier function was assessed by measuring transendothelial electrical resistance (TEER)
as previously described (Al Ahmad et al., 2009). Cell viability was assayed using an
ADAM fluorescent cell counter (Witec AG, Littau, Switzerland). Living cells were
expressed as a percentage of total cell count.
Cellular ROS generation and GSH measurements
ROS formation was quantified by fluorometry techniques based on DCF oxidation,
whereas GSH measurement was obtained using colorimetry technique with protocols
previously published in the literature (Bogdanova et al., 2005; Petrushanko et al., 2006).
Statistical analysis
All results are expressed as mean ± SD from three independent experiments. Statistical
significance was assessed by analysis of variance using appropriate tests. A p-value
below 0.05 was considered significant.
RESULTS
We firstly monitored oxidative stress in RBE4 cells during O2 deprivation insult using
DCF, a fluorescent dye sensitive to ROS compounds (Figure 1A). Hypoxic stress was
not efficient to generate detectable ROS formation in RBE4 monolayers, as we noted no
differences in DCF fluorescence compared to normoxia. However near-anoxic
conditions strongly induced ROS formation, as we noted a significant increase in DCF
fluorescence. Following such observation, we measured reduced glutathione
(GSH)/oxidized glutathione (GSSG) ratio in cells exposed to hypoxia or near-anoxia for
24h (Fig.1B). Under hypoxic stress, such ratio was significantly increased compared to
control condition, suggesting an up-regulation in GSH synthesis. However, under near-
anoxic conditions the ratio was significantly lower suggesting the onset of oxidative
stress in RBE4 monolayers and correlating with the DCF data.
As O2 deprivation induced ROS formation in RBE4 monolayers, we investigated the
impact of oxidative stress on barrier function in normoxic cells. Presence of 200 µM
BSO (an inhibitor of GSH synthesis) transiently decreased TEER (Fig.2A). However,
the presence of 10µM rotenone significantly decreased TEER compared to control
condition. Such decrease in barrier function was unlikely related to cell-death mediated
mechanisms, as no cell death was noted after 24h (Fig.2B).
To better correlate hypoxia-induced barrier breakdown and increase oxidative stress, we
investigated the effect of anti-oxidant treatment on barrier function using 5mM NAC,
100µM DFO or 10µM DPI as anti-oxidant reagents (Fig.3). Under hypoxic condition
(Fig.3A), presence of NAC, DFO or DPI did not significantly affect TEER values
compared to control during acute exposure (less than 8h). DPI treatment partially
maintained barrier function already by 24h, whereas DFO- or NAC-treated cells showed
improvement only after 48h. Under near-anoxic condition (Fig.3B), all but DFO
treatment allowed RBE4 cells to maintain higher TEER than vehicle-treated group from
6h to 48h. Again, no significant improvements were noted following reoxygenation.
Notably cell survival following prolonged (48h) hypoxic injury was improved by all
three treatments, whereas DPI treated-group only showed significant improvement in
near-anoxic cells (Fig.4A). Finally, we investigated the effect of astrocyte and pericyte
co-cultures on the GSH ratio in RBE4 cells (Fig.4B). After 24h of normoxia, no
significant differences were observed between monocultures and co-cultures. However,
after 24h of hypoxia, pericyte co-cultures showed a three-fold decrease in GSH/GSSG
ratio whereas astrocyte co-cultures showed no differences compared to monocultues.
DISCUSSION
O2 deprivation injury constitutes one of the most challenging pathophysiological
mechanisms leading to BBB breakdown. Although some of the cellular and molecular
mechanisms triggering such breakdown are better understood, existence of an
therapeutical arsenal capable of restoring BBB function remains largely missing. Recent
description of oxidative stress occurring under O2 deprivation insult (Chandel et al.,
1998) raises the possible contribution of ROS signaling to BBB breakdown. In this
study, we provide evidence of the involvement of ROS in RBE4 barrier function
disruption during hypoxia, a condition known to induce vascular leakage in ECs (Al
Ahmad et al., 2009). We demonstrate that oxidative stress significantly contributes to
barrier breakdown due to the fact that artificial generation of ROS increased ECs barrier
breakdown, whereas treatment of RBE4 monolayers with anti-oxidants during O2
deprivation stress resulted in overall improvement of both barrier function and cell
survival. Although we did not identify the specific chemical nature of such pro-oxidant
species, we can speculate that the effects are likely driven through different species.
H2O2 formation through Fenton’s reaction is known to induce barrier leakage (Kim et
al., 2008; Lee et al., 2004; Yamagata et al., 2004). However inhibition of H2O2 by DFO
(an iron chelator) was beneficial only under hypoxia. On the other hand, DPI (an
NADPH oxidase inhibitor) or NAC (glutathione analog) were efficient both under
hypoxic and near-anoxic treatment suggesting that ROS products distinct from H2O2
may occur under such severe conditions.
Among the different protective mechanisms developed by mammalian cells to fight
against such oxidative stress, glutathione is certainly the most prominent (Dickinson et
al., 2003). Using GSH/GSSG ratio as a marker of oxidative stress, we observed that
hypoxic cells showed the highest ratio whereas near-anoxic cells showed the lowest ratio
suggesting that an impaired redox cellular homeostasis may contribute to hypoxia-driven
barrier breakdown. Such impairment appeared crucial during oxidative stress as artificial
supplementation of reduced glutathione (using NAC) improved both barrier function and
cell survival. On the other hand, a direct inhibition of ROS generation by DPI showed the
most potent effect in maintaining barrier function and improving cell survival, whereas
attempts to selectively inhibit only one ROS by-product (H2O2 by DFO) appeared
limited. Thus, a combined inhibition approach (by simultaneously inhibiting ROS
generation and increasing reduced glutathione bioavailability) may help in reducing BBB
leakage and improving its restoration.
As the BBB is a multicellular unit, it is important to consider the potential modulatory
effects of astrocytes and pericytes on EC response to oxidative stress. Previous studies
highlighted the ability of astrocytes to “buffer” oxidative stress when co-cultured with
brain ECs (Schroeter et al., 1999), whereas a recent study highlighted the high
susceptibility of brain pericytes to oxidative stress (Price et al., 2012). Furthermore, we
previously demonstrated that astrocytes but not pericytes maintained better barrier
function following mild hypoxia (Al Ahmad et al., 2009). Using glutathione ratio to
assess oxidative stress, we noted a significant decrease in the pericyte co-culture ratio
after 24 hours of hypoxia compared to monocultures and astrocyte co-cultures. This data
agrees with a previous study that highlighted the negative impact of EC-generated ROS
on pericyte function (Amano et al., 2005). Our observations may partially explain the
differential response observed between astrocyte and pericyte co-cultures on barrier
function and raises the question whether pericytes respond to oxidative stress only under
severe conditions. Based on our current data, we can speculate that the generation of
distinct ROS by-products by EC monolayers may condition the cellular response of
astrocytes and pericytes to oxidative stress. Thus further investigations are necessary to
shed light on the cellular mechanisms underlying astrocyte and pericyte response to such
oxidative stress.
Finally, the concomitant presence of oxidative stress and O2 deprivation raises the
question of whether hypoxia-induced factor (HIF) pathways modulate the cellular
response to hypoxia-induced oxidative stress (Fandrey and Gassmann, 2009). It has been
suggested that increased oxidative stress may increase HIF-1 activity (Tajima et al.,
2009), which in turn may decrease GSH biosynthesis (Jackson and Gupta, 2010). Such
hypothesis requires further investigation in order to understand the contribution of HIF-1
to changes in GSH content in RBE4 monolayers during O2 deprivation injury.
In summary this study provides insight into the effect of oxidative stress on BBB function
during hypoxia insult and shed a new light on the roles played by astrocytes and pericytes
regarding such stress. This study suggests that the generation of reactive oxygen species
is somewhat proportional to O2 deprivation severity and contributes to hypoxia-induced
barrier breakdown. The ability of brain ECs to cope with stress endogenously (through
the glutathione metabolism) or by involving neighboring cells (astrocytes and pericytes)
determines whether the barrier maintains its function or is compromised.
As recently suggested (Freeman and Keller, 2012; Ogunshola, 2011) the BBB likely
constitutes the first interface of the central nervous system confronted by oxidative stress
following stroke or indeed any cerebrovascular disease and an impaired response, or
disruption of function, would directly impact neuronal integrity and survival. Thus, a
better understanding of how the BBB copes with oxidative stress may represent a
promising target to simultaneously fight ongoing oxidative stress at the injured site but
also foster a restoration of the barrier function following acute and chronic
cerebrovascular diseases.
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FIGURES LEGEND
Figure 1: Near-anoxia induces excessive ROS formation in RBE4 monolayers.
A: ROS production was measured by DCF fluorescence in cells pre-incubated under
hypoxic or near-anoxic condition. 1 hour before the end of experiments, 10µM DCFDA
was added. Cells were lyzed to measure cellular DCF fluorescence. n=3, ** P<0.01 vs.
21% O2, ## P<0.01 vs. 1% O2. B: Reduced GSH and oxidized GSH (GSSG) were
measured in cells exposed for 24h to hypoxia or near-anoxia. n=3, *P<0.05 and **
P<0.01 vs. 21% O2, ## P<0.01 vs. 1% O2.
Figure 2: Pro-oxidative stress induces barrier leakage under normoxic conditions.
A: TEER measurements were performed in RBE4 monolayers exposed to 200µM BSO
or 10µM rotenone. Vehicle group (0.1% DMSO) was used as a timeline control. n=3,
*P<0.05 and ** P<0.01 vs. vehicle. B: Cell survival was assessed in cells exposed for
48h to BSO or rotenone. Number of living cells was normalized to total cell count. n=3.
Figure 3: Anti-oxidant treatment partially prevent hypoxia-induced BBB breakdown
TEER measurements were performed in RBE4 monolayers exposed to hypoxia (A) or
near-anoxia (B). 100µM DFO, 10µM DPI or 5mM NAC were added 1h before
experimental start. Vehicle group (0.1% DMSO) was used as a timeline control.
Reoxygenation was performed by incubating cells in fresh medium at 21% O2 for 24h.
n=3, *P<0.05 and **P<0.01 vs. vehicle.
Figure 4: Effect of anti-oxidant treatment and co-culturing on ECs cell survival and
redox status
A: Cell survival was assessed in cells exposed for 48h to hypoxia or near-anoxia in
presence of DFO, DPI or NAC. Living cells were normalized over total cell count. n=3.
*P<0.05 versus vehicle-treated group. B: Effect of co-culturing astrocytes and pericytes
on ECs redox status. Co-cultures were incubated for 24h either under normoxic (21% O2)
or hypoxic (1% O2) condition. n=3, *P<0.05 and **P<0.01 vs. 21% O2.
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